Summary
UnitedHealth Group Inc. (UNH) filed an 8-K on October 19, 2006, to report on its third-quarter 2006 financial results. The filing includes a press release detailing these results and provides reconciliations for non-GAAP financial measures used by management. Notably, the company presents "Part D Normalized" results to facilitate comparison with the prior year by normalizing Medicare Part D benefit costs. Additionally, it discloses certain financial measures excluding its AARP business to highlight operational performance independent of the AARP program's unique accounting treatment. The report also addresses significant ongoing matters, including an independent committee's investigation into stock option practices, related governmental reviews, and associated litigation. These issues have led to management and director changes and are expected to cause delays in filing the quarterly report for the period ending September 30, 2006. Investors should be aware that these events introduce considerable uncertainty regarding future financial reporting and potential accounting restatements.
Key Highlights
- 1UnitedHealth Group reported its third-quarter 2006 results via an 8-K filing on October 19, 2006.
- 2The company utilizes and reconciles "Part D Normalized" non-GAAP measures to provide a more comparable view of results against prior periods, specifically addressing Medicare Part D benefit costs.
- 3Financial data is also presented excluding the AARP business to isolate operational performance from specific accounting treatments related to that program.
- 4The filing acknowledges an ongoing investigation into the company's stock option practices by an independent committee.
- 5Consequent to the stock option investigation, management and director changes have occurred, and a delay in filing the Q3 2006 Form 10-Q is anticipated.
- 6The company faces potential accounting adjustments and disclosures, including the possibility of restating previously filed financial statements.
- 7UNH highlights significant risks and uncertainties, including the stock option investigation, potential litigation, regulatory reviews, and impacts on credit ratings and debt.